Pharmaceutical Information |
Drug Name |
Patiromer |
Drug ID |
BADD_D01686 |
Description |
Patiromer is a powder for suspension in water for oral administration, approved in the U.S. as Veltassa in October, 2015. Patiromer is supplied as patiromer sorbitex calcium which consists of the active moiety, patiromer, a non-absorbed potassium-binding polymer, and a calcium-sorbitol counterion. Each gram of patiromer is equivalent to a nominal amount of 2 grams of patiromer sorbitex calcium. The chemical name for patiromer sorbitex calcium is cross-linked polymer of calcium 2-fluoroprop-2-enoate with diethenylbenzene and octa-1,7-diene, combination with D-glucitol. Patiromer sorbitex calcium is an amorphous, free-flowing powder that is composed of individual spherical beads. |
Indications and Usage |
For the treatment of hyperkalemia. |
Marketing Status |
Prescription |
ATC Code |
V03AE09 |
DrugBank ID |
DB09263
|
KEGG ID |
D11037
|
MeSH ID |
C568789
|
PubChem ID |
Not Available
|
TTD Drug ID |
D0Z2YQ
|
NDC Product Code |
53436-252; 53436-084; 53436-168 |
Synonyms |
patiromer | Veltassa | RLY 5016 | RLY5016 | RLY-5016 |
|
Chemical Information |
Molecular Formula |
Not Available |
CAS Registry Number |
1260643-52-4 |
SMILES |
Not Available |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
End stage renal disease | 20.01.03.019 | - | | Not Available |
|
|
|